Nosa Plugs AB publ OMXSTO:NOSA:
REPORT SHOWS DRUG PLATFORM ACHIEVES THERAPEUTIC LEVELS IN BRAIN
NOSA Gets Positive Data From In-Vivo Drug Delivery Study
Earlier from Nosa Plugs
- Nosa Plugs Q3 Net Sales Down At SEK 3.6 Mln
- Nosa Plugs Odor Control Procured In Norway For Healthcare Products
- NOSA: Q2 saw 17% sales growth, improved margins, and a major acquisition, supporting 2025 profitability goals
- NOSA: Acquisition of Pharmacure for 27.2 MSEK boosts growth and market reach in nasal health
- NOSA: 50% sales growth and first positive cash flow mark a strong Q1 for NOSA
Later from Nosa Plugs
- Nosa Plugs Begins Collaboration With Abena Sweden
- NOSA: 49% revenue growth and strategic acquisition fueled expansion, with positive Q4 EBITDA
- NOSA Launches Nozoil in Austria Together with PHOENIX
- Nosa Plugs Unit Gets Vinnova Funding Under Medtech4health Program
- NOSA: Net sales surged 94% year-over-year, with margin gains and expanded European distribution
Follow Nosa Plugs into a list and get an email when it puts out news.
Follow Nosa Plugs